Elan Corporation

DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 14, 2004--Elan Corporation, plc announced today that it will host a conference call on Thursday, October 28, 2004 at 8:30 a.m. Eastern Time (ET), 1:30 p.m. British Summer Time (BST) with the investment community to discuss Elan's third quarter 2004 financial results, which will be released before the U.S. and European financial markets open.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to investors, members of the news media and the general public.

This event can be accessed by visiting Elan's website at www.elan.com and clicking on the Investor Relations section, then on the event icon. Following the live webcast, an archived version of the call will be available at the same URL.

About Elan

Elan is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing, selling and marketing advanced therapies in neurodegenerative diseases, autoimmune diseases and severe pain. Elan's (NYSE:ELN) shares trade on the New York, London and Dublin Stock Exchanges.

CONTACT: Elan
Investors
Emer Reynolds, 353-1-709-4000
800-252-3526
or
Media
Anita Kawatra, 212-407-5740
800-252-3526

SOURCE: Elan Corporation, plc